STAT
SEPTEMBER 15, 2022
Artificial intelligence is a transformative tool in the workplace — except when it isn’t. For top managers, state-of-the art AI tools are a no-brainer: in theory, they increase revenues, decrease costs, and improve the quality of products and services. But in the wild, it’s often just the opposite for frontline employees who actually need to integrate these tools into their daily work.
Pharmacy Times
SEPTEMBER 15, 2022
Triplet combination demonstrates a reduction in the risk of disease progression or death in individuals with previously untreated advanced intermediate- or poor-risk renal cell carcinoma.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
SEPTEMBER 15, 2022
Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database.
Pharmacy Times
SEPTEMBER 15, 2022
Researchers have identified hydroquinine as a potential treatment against drug-resistant bacteria, which can cause infections with a 70% mortality rate.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
SEPTEMBER 15, 2022
The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.” The Swiss Competition Commission (COMCO) arrived unexpectedly at Novartis at dawn on Tuesday morning, to gather information on an unidentified dermatology drug, as part of a wider investigation into the drugmaker by the European Commission.
Pharmacy Times
SEPTEMBER 15, 2022
Deucravacitinib is a selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, which is a member of the Janus kinase (JAK) family.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
SEPTEMBER 15, 2022
Covid-19 demonstrated how quickly the United States can mobilize to produce and distribute new tests, vaccines, and treatments for a previously unknown virus. The pandemic also highlighted significant inequalities and gaps in its health care system, with many rural and underserved urban areas lacking sufficient access to care. Amid those two realities, pharmacists played a central role in providing access to testing, vaccination, and treatment, especially for older and socioeconomically vulnerab
Drug Topics
SEPTEMBER 15, 2022
William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children of all ages and describes what is on the horizon for RSV.
STAT
SEPTEMBER 15, 2022
As new abortion bans are enacted around the country, physicians working with pregnant patients are facing potential ethical and legal dilemmas. Even if a law allows for an exception when the life of the mother is at risk, there are no clear answers for doctors trying to decide if and when they can act. Matthew Wynia is a physician who has spent decades focused on medical ethics, including roles at the helm of the Ethics Institute at the American Medical Association and the Ethics
Pharmacy Times
SEPTEMBER 15, 2022
Pharmacists should ascertain whether self-treatment is appropriate and suggest medical care if it isn’t.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
SEPTEMBER 15, 2022
Medicare is vastly underserving older Americans with opioid use disorder, with only 18% of enrollees with the diagnosis receiving recommended medication treatment, according to a new federal oversight report. The report, from the U.S. health department’s Office of Inspector General, also found that more than 50,000 Part D beneficiaries overdosed on opioids in 2021, whether painkillers or illicit drugs.
pharmaphorum
SEPTEMBER 15, 2022
The potential for technology to transform the way we deliver healthcare is nothing new. We’ve been discussing it for some years now and are starting to see more widespread adoption, particularly post-pandemic. But the area where I believe technology can have the greatest impact – and where there is still plenty of work to do – is women’s health. Today, women spend around a quarter of their lives in poor health or disability, compared with one fifth for men.
STAT
SEPTEMBER 15, 2022
The Swiss Competition Commission has begun an investigation into Novartis over the possible unlawful use of a patent to block competitors for some of its medicines, the latest instance in which European authorities have probed drug companies for antitrust infractions. Earlier this week, the Swiss agency conducted a dawn raid on Novartis headquarters in Basel, Switzerland, seeking information about efforts the company allegedly made to protect a drug for an unspecified skin treatment.
ISPE
SEPTEMBER 15, 2022
Annex 1 Implementation Strategies. Trudy Patterson. Thu, 09/15/2022 - 13:50. iSpeak Blog. iSpeak. Annex 1 Implementation Strategies. Thomas Zimmer, PhD. 15 September 2022. Annex 1 of the EC GMP Guide " Manufacture of Sterile Medicinal Products " has a long history. First published in 1989, there have been a total of 5 adaptations in 1996, 2003, 2005, 2007 and 2009, but no complete revision.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
SEPTEMBER 15, 2022
A host of health tech startups and companies are advertising their apps and platforms as key solutions to improving diversity in clinical trials, promising to help researchers improve their outreach, enrollment, and retention — what one researcher calls a “modern-day gold rush.” The Power platform focuses on breaking down medical jargon and helping users connect with trial sponsors nearby.
Drug Store News
SEPTEMBER 15, 2022
According to a survey by Reach 3 Insights, 80% of Americans say that rising prices have driven them to purchase more store-brand products.
STAT
SEPTEMBER 15, 2022
In a victory for Gilead Sciences, Brazilian antitrust authorities dismissed a complaint filed by several advocacy groups that alleged the company charged “abusive” prices for a hepatitis C treatment. In their filing , which was made in 2019, the groups argued that “unlawful conduct” carried out by Gilead had hurt the public interest, because its prices led the government to ration the Sovaldi medication.
Drug Store News
SEPTEMBER 15, 2022
The beauty category, most notably the skin care space, has seen a massive resurgence in the demand for environmentally friendly, clean, vegan and cruelty-free products.
STAT
SEPTEMBER 15, 2022
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Drug Store News
SEPTEMBER 15, 2022
Dr. Scholl’s is working with former head football coach and analyst Rex Ryan and surgeon Brad Schaeffer of TLC’s “My Feet Are Killing Me” on the launch of its Instant Cool Athlete’s Foot solutions.
STAT
SEPTEMBER 15, 2022
Rise and shine, everyone, another busy day is on the way. This morning is getting off to a fabulous start, though, as a delightfully cool breeze and warm sun are enveloping the subdued Pharmalot campus, where the official mascot is snoozing nearby. As always, we are quaffing some cups of stimulation — chocolate raspberry is our choice du jour — and assembling some tidbits for your pleasure.
Pharma Tutor
SEPTEMBER 15, 2022
AN APPROACH TO THE HAIR FALL & HAIR GROWTH MANAGEMENT. About Authors Avdesh Thassu. MPharm (Nat. Chem.); MBA(Mkt.). Associate Vice President. Global Regulatory Affairs, Emami Limited, 7044455199. athassu@hotmail.com. Chandra Mohan Nandi. MSc. (Organic Chem.). Deputy Manager, Global Regulatory Affairs, Emami Limited, 9051706947 chandramohannandi@yahoo.in. admin.
pharmaphorum
SEPTEMBER 15, 2022
Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. Terlipressin – now given the brand name Terlivaz – has become the first and only FDA-approved treatment for adults with HRS who are experiencing a rapid reduction in kidney function, a life threatening condition, getting the green light well ahead of the FDA’s deadline date of 9 December.
Pharmacy Times
SEPTEMBER 15, 2022
Alopecia areata is an autoimmune disease with an underlying immuno-inflammatory pathogenesis.
PharmaVoice
SEPTEMBER 15, 2022
Sonara Health’s inexpensive, specially engineered label and web app allow for at-home, digitally supervised dosing of high-cost or high-risks drugs.
Drug Store News
SEPTEMBER 15, 2022
Albertsons is working with WinnCompanies to provide grocery, prescription and vaccination resources to seniors and families.
European Pharmaceutical Review
SEPTEMBER 15, 2022
Investing close to €300 million, Takeda plans to construct a new state-of-the-art production facility for plasma-derived therapies and a net-zero carbon emissions warehouse in Lessines, Belgium – the largest investment Takeda has ever made in the country. The investment is part of the company’s global effort to implement the most innovative technologies and most sustainable processes at its manufacturing sites.
Drug Store News
SEPTEMBER 15, 2022
Utilizing Amazon Customer Engagement’s Tailored Audiences, sellers can now increase their email marketing reach and build brand loyalty, the company said.
European Pharmaceutical Review
SEPTEMBER 15, 2022
According to Novartis, Kisqali ® (ribociclib) plus endocrine therapy in the first-line setting added nearly a year of additional overall survival (OS) benefit in a subgroup of patients with aggressive forms of hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer (aBC). The pooled exploratory analysis from the MONALEESA Phase III programme revealed that patients with visceral metastases, including liver metastases and multiple metastatic
Pharmacy Times
SEPTEMBER 15, 2022
Part A results from the 2-part LILAC study show that the therapy significantly reduced disease activity based on active joint count in individuals compared with the placebo.
European Pharmaceutical Review
SEPTEMBER 15, 2022
Long-term data from the KEEPsAKE trials shows more than half of adult psoriatic arthritis patients receiving Skyrizi ® (risankizumab, 150mg) achieving a 90 percent reduction in the Psoriasis Area and Severity Index (PASI 90) and an American College of Rheumatology 20 (ACR20) response at 100 weeks. The long-term data analyses of the Phase III KEEPsAKE 1 and 2 trials also revealed no new observed safety signals through 100 weeks.
Pharmacy Times
SEPTEMBER 15, 2022
Services such as managing/updating patient programs and working with non-profits can go a long way in healthcare education for patients.
The Guardian - Pharmaceutical Industry
SEPTEMBER 15, 2022
TGA report recommends reduced packet sizes and restricting over-the-counter sales of the drug to people 18 and over Follow our Australia news live blog for the latest updates Get our free news app , morning email briefing or daily news podcast The size of paracetamol packets sold in supermarkets could be reduced and limits introduced on the number of boxes that can be bought, in a bid to reduce injury and death from intentional overdoses.
Outsourcing Pharma
SEPTEMBER 15, 2022
Australian CRO Avance Clinical has expanded in North America by acquiring C3 Research Associates, positioning it to continue supporting sponsors as they move into later-phase studies that need US sites.
Expert insights. Personalized for you.
128 
Let's personalize your content